drugset / Trial / NCT00037141

Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)

NCT00037141

Phase 1/2 Completed 150 enrolled American Medical Systems
RandomizedParallel-groupTreatment

Summary

Multi-center, prospective randomized dosing and safety research study. A maximum of 150 men will be enrolled in the study. Qualifying patients will receive one of three possible doses of the study drug. Symptoms will be evaluated before treatment, and then 1-week, 1-month, 3-months, and 6-months following treatment.

Timeline

Start
2002-03
Primary completion
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Alcohol Other / unclassified Other